Tyra Biosciences, Inc.
TYRA
$36.22
$0.220.61%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 29.83M | 29.07M | 27.50M | 25.89M | 24.13M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 132.76M | 125.99M | 121.65M | 113.73M | 104.20M |
| Operating Income | -132.76M | -125.99M | -121.65M | -113.73M | -104.20M |
| Income Before Tax | -119.95M | -111.68M | -105.83M | -96.44M | -86.48M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -119.95 | -111.68 | -105.83 | -96.44 | -86.48 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -119.95M | -111.68M | -105.83M | -96.44M | -86.48M |
| EBIT | -132.76M | -125.99M | -121.65M | -113.73M | -104.20M |
| EBITDA | -132.22M | -125.43M | -121.10M | -113.19M | -103.68M |
| EPS Basic | -2.01 | -1.88 | -1.79 | -1.63 | -1.51 |
| Normalized Basic EPS | -1.26 | -1.17 | -1.12 | -1.02 | -0.94 |
| EPS Diluted | -2.01 | -1.88 | -1.79 | -1.63 | -1.51 |
| Normalized Diluted EPS | -1.26 | -1.17 | -1.12 | -1.02 | -0.94 |
| Average Basic Shares Outstanding | 238.39M | 237.62M | 236.82M | 235.94M | 228.83M |
| Average Diluted Shares Outstanding | 238.39M | 237.62M | 236.82M | 235.94M | 228.83M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |